Clinical Trials Logo

Filter by:
NCT ID: NCT05393609 Recruiting - Quality of Life Clinical Trials

Quality of Life and Surgery in Diverticular Disease

Start date: April 22, 2022
Phase:
Study type: Observational [Patient Registry]

Diverticular disease is one of the most common diseases of the gastrointestinal tract in industrial countries. Prevalence and admission rate due to diverticular disease increases. Symptomatic patients usually present with acute uncomplicated or complicated diverticulitis. Recurrence rates of complicated diverticulitis are estimated to 10-30%. Recurrences, chronic complications or persisting pain, here collectively referred to as chronic diverticular disease, may be treated by elective sigmoidectomy. Currently, there is no specific criteria for elective surgery, but only a recommendation of a tailored approach depending on the patient's symptoms. It is well established that diverticular disease has a negative impact on quality of life (QoL). Elective laparoscopic sigmoidectomy may increase QoL. In this prospective study, we will prospectively examine QoL, patient-related outcomes and peri- and postoperative outcome of elective sigmoidectomy for chronic diverticular disease, and compare it to conservatively treated patients.

NCT ID: NCT05393115 Recruiting - Healthy Clinical Trials

Respiratory Muscle Fatigue at Different Breathing Modes

Start date: October 1, 2021
Phase: N/A
Study type: Interventional

The study aims at investigating if time to respiratory muscle fatigue and metabolism are influenced by the pressure wave form mode applied during resistive breathing.

NCT ID: NCT05390268 Recruiting - Tic Disorders Clinical Trials

Mobile App-assisted Behavioral Treatment in Children and Adolescents With Tics

Start date: April 30, 2022
Phase: N/A
Study type: Interventional

Chronic tic disorders are neurodevelopmental disorders affecting 0.5-1% of children and adolescents. Tics present as sudden, rapid, repetitive non-rhythmic movements or vocalizations or a combination. Tics may be extremely distressing in a child's life, but the severity of tics is often variable. The group of children/ adolescents with tic disorders are heterogenous when it comes to symptom presentation, comorbid conditions and social status. This places great demands on professionals to offer the right treatment at the right time. The aim of the current project is to make optimal tics training more accessible, including for patients managed in primary care, to make optimal treatment available in the immediate environment, and to ensure increased adherence to treatment. As part of this project, an app has been developed and the study aims to evaluate mobile app-assisted behavioral treatment as an efficient and feasible approach that may be a valuable tool together with other treatment approaches. The mobile app-assisted training is based on the manual "Niks til Tics", which describes training with a combination of Habit Reversal Training (HRT) and Exposure Response Prevention (ERP) over nine sessions. Both HRT and ERP are known to be effective treatments of tics. In this project a randomized controlled superiority trial evaluates the effect of app-assisted training versus an educational approach. Participants are randomized to manualised treatment combining HRT and ERP as app-assisted training, or to one session of psychoeducation supplemented with access to videos repeating the information. The participants are included according to the same criteria as in a pilot trial, and primary outcome measure is YGTSS at session 8. Furthermore, the change in tics intensity from baseline to randomization will be included as to evaluate the effect of being admitted and examined at the hospital. This project contributes to increased knowledge about tics and tic treatment especially treatment using digital based interventions. An app has been developed for this project and the hypothesis is that a mobile app-assisted tic training program requiring minimal hospital contacts is superior to app-based psychoeducation alone, which is the most likely intervention that these patients will be offered.

NCT ID: NCT05389566 Recruiting - Diabetes Clinical Trials

Diabetes, Falls, and Fractures

DIAFALL
Start date: May 6, 2022
Phase:
Study type: Observational

Comparing severity of diabetic peripheral neuropathy (small and large fibers including autonomic neuroapthy) to postural control and vestibular measurements

NCT ID: NCT05389436 Recruiting - Ankle Fractures Clinical Trials

Outpatient Versus Inpatient Surgery for Ankle Fractures

OVISAF
Start date: May 23, 2022
Phase: N/A
Study type: Interventional

This study is a single center randomized controlled trail in which we compare outpatient and inpatient patients with an ankle fracture requiring surgical treatment.

NCT ID: NCT05385822 Recruiting - Clinical trials for Erectile Dysfunction

Pelvic Floor Muscle Training in the Treatment of Erectile Dysfunction

Start date: May 1, 2022
Phase: N/A
Study type: Interventional

Erectile dysfunction affects about 40% of all men above the age of 40 and the prevalence increases with increasing age. It is not possible to cure the condition as current forms of treatment are aimed solely at improving symptoms. Treatment options today include medications, injection therapy, and vacuum pumps, among others. However, pelvic floor muscle training is a natural, inexpensive, and non-invasive form of treatment that is used to a limited extent. Theoretically, a strengthening of the pelvic floor muscles can help increase the intracavernous pressure and thereby the hardness of the erection. Furthermore, tense pelvic floor muscles can help compress pelvic veins and reduce blood flow away from the penis which prolongs the erection. Finally, it is possible that pelvic floor muscle training can contribute to an increased blood supply to the pelvic floor and the penis which will have positive effects in relation to both the integrity of the penile tissue and the physiological erection mechanism itself. This study aims to investigate the effect of pelvic floor muscle training in men with erectile dysfunction. The study hypothesis is that pelvic floor training can provide a clinically significant improvement in the erection function at individual patient level

NCT ID: NCT05385796 Recruiting - Clinical trials for Heel Fat Pad Syndrome

STEP Trial for Heel Fat Pad Syndrome

STEP
Start date: June 8, 2022
Phase: N/A
Study type: Interventional

The primary objectives of this study are to investigate the immediate and short-term effect of heel fat pad loop taping (experimental intervention) vs. control taping (control intervention) on pain and function in individuals with heel fat pad syndrome (HFPS). For mechanistic understanding of the effect of the loop taping, we will assess the immediate effect of taping on the pressure pain threshold and heel fat pad thickness.

NCT ID: NCT05385627 Recruiting - Clinical trials for Surgical Procedure, Unspecified

Local Infiltration Analgesia for Foot Surgery

Start date: May 12, 2022
Phase:
Study type: Observational [Patient Registry]

Prospective cohort assessing the effects of ankle block (local infiltration analgesia) on duration of analgesia, pain, opioid consumption, and patient satisfaction.

NCT ID: NCT05385250 Recruiting - Anal Cancer Clinical Trials

Bone-sparing Chemoradiotherapy for Anal Cancer - DACG-II

DACG-II
Start date: August 23, 2021
Phase: N/A
Study type: Interventional

This study proposal includes a prospective clinical trial of bone sparing treatment planning in anal cancer patients. We seek to lower the risk of bone damage, while adhering with the constrains to the bowel, bladder and other conventional Organs At Risk, and finally to describe the fraction of pelvic insufficiency fractures in patients treated with optimized radiotherapy.

NCT ID: NCT05385081 Recruiting - Clinical trials for Metastatic Solid Tumor

PREcision Medicine in Cancer in Odense, Denmark

PRECODE
Start date: March 1, 2019
Phase: N/A
Study type: Interventional

The traditional approach to cancer treatment has changes from using drugs approved for the specific cancer diagnosis to a tumor agnostic approach when treating solid tumors. How often will tumor biopsy and genomic profiling in patients with advanced solid tumors with no further evidence based treatment options result in biomarker-driven targeted treatment ? Feasibility of the investigation of patients and median turnaround time from biopsy to available genomic profile is evaluated.